The role of levosimendan and ivabradine in cardio-oncology: acute doxorubicin toxicity

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Case Corner 5 - Cardio-oncology pearls Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by